Hot Life Science Investor Mandate 3: Spanish VC Firm Seeking Therapeutics, Diagnostics and Medical Devices Throughout EU and US

19 Mar

A Spanish independent venture capital firm is currently providing private equity financing to early- and mid-stage human healthcare and life science companies. The firm has € 118 million in assets under management distributed over two funds. The second fund has a target size of € 100 million and will remain open to new investors until September 2015. The firm can allocate up to €7M (in equity) per company, generally co-investing with other specialized investors. The firm looks for companies that are based in Europe and the US.

The firm targets the entire healthcare and biotechnology industry, with a special focus on pharmaceuticals, diagnostics and medical devices. The firm is opportunistic in terms of indications and seeks products that have an attractive market potential. In case of niche/orphan indications, the potential market share should be significant and realistic. For therapeutics, the firm invests in small molecules, biologics and advanced therapies. At minimum, the product should have a solid animal data. For medical devices, the firm is also opportunistic and looks for devices that have a working prototype.

The firm looks for a cohesive management team with a proven track record, including relevant business experience and top-notch scientific know-how. The firm requires a board seat in each portfolio company.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: